Xavier Matias-Guiu Guia
Grau: Doctor/a
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Grups
Publicacions
-
Hellner, K; Miranda, F; Fotso Chedom D; Herrero-Gonzalez, S; Hayden, DM; Tearle, R; Artibani, M; KaramiNejadRanjbar, M; Williams R; Gaitskell, K; Elorbany, S; Xu, RY; Laios, A; Buiga, P; Ahmed, K; Dhar, S; Zhang, RY; Campo, L; Myers, KA; Lozano, M; Ruiz-Miro, M; Gatius, S; Mota, A; Moreno-Bueno, G; Matias-Guiu, X; Benitez, J; Witty, L; McVean, G; Leedham, S; Tomlinson, I; Drmanac, R; Cazier, JB; Klein, R; Dunne, K; Bast, RC; Kennedy, SH; Hassan, B; Lise, S; Garcia, MJ; Peters, BA; Yau, C; Sauka-Spengler, T; Ahmed, AA
Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies
EBioMedicine 10 137-149. .
-
Mirantes, C; Dosil, MA; Eritja, N; Felip, I; Gatius, S; Santacana, M; Matias-Guiu, X; Dolcet, X
Effects of the multikinase inhibitors Sorafenib and Regorafenib in PTEN deficient neoplasias
EUROPEAN JOURNAL OF CANCER 63 74-87. .
-
Campoy, I; Lanau, L; Altadill, T; Sequeiros, T; Cabrera, S; Cubo-Abert, M; Perez-Benavente, A; Garcia, A; Borros, S; Santamaria, A; Ponce, J; Matias-Guiu, X; Reventos, J; Gil-Moreno, A; Rigau, M; Colas, E
Exosome-like vesicles in uterine aspirates: a comparison of ultracentrifugation-based isolation protocols
Journal Of Translational Medicine 14 180-180. .
-
Santacana M; Coronado P; Matias-Guiu X; Romero I; Casado A; Gil-Moreno A; Dosil MA; Mota A; Moreno-Bueno G; Dolcet X; Llombart-Cussac A; Poveda A
Biological Effects of Temsirolimus on the mTOR Pathway in Endometrial Carcinoma: A Pharmacodynamic Phase II Study.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER -. .
-
Schultheis, AM; Ng, CKY; De Filippo, MR; Piscuoglio, S; Macedo, GS; Gatius, S; Perez Mies B; Soslow, RA; Lim, RS; Viale, A; Huberman, KH; Palacios, JC; Reis-Filho, JS; Matias-Guiu, X; Weigelt, B
Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 108 -. .
-
Fuste, NP; Castelblanco, E; Felip, I; Santacana, M; Fernandez-Hernandez, R; Gatius, S; Pedraza, N; Pallares, J; Cemeli, T; Valls, J; Tarres, M; Ferrezuelo, F; Dolcet, X; Matias-Guiu, X; Gari, E
Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer
Oncotarget 7 26979-26991. .
-
Yeramian, A; Vea, A; Benitez, S; Ribera, J; Domingo, M; Santacana, M; Martinez, M; Maiques, O; Valls, J; Dolcet, X; Vilella, R; Cabiscol, E; Matias-Guiu, X; Marti, RM
2-phenylethynesulphonamide (PFT-) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels
PIGMENT CELL & MELANOMA RESEARCH 29 352-371. .
-
Mirantes, C; Dosil, MA; Hills, D; Yang, J; Eritja, N; Santacana, M; Gatius, S; Vilardell, F; Medvinsky, A; Matias-Guiu, X; Dolcet, X
Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies
Blood 127 1907-1911. .
-
Eritja, N; Arjo, G; Santacana, M; Gatius, S; Ramirez-Nunez, O; Arcal, L; Serrano, JCE; Pamplona, R; Dolcet, X; Pinol, C; Christou, P; Matias-Guiu, X; Portero-Otin, M
Oral intake of genetically engineered high-carotenoid corn ameliorates hepatomegaly and hepatic steatosis in PTEN haploinsufficient mice
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1862 526-535. .
-
Vaquero, M; Macia, A; Anerillas, C; Velasco, A; Matias-Guiu, X; Ribera, J; Encinas, M
Sprouty1 haploinsufficiency accelerates pheochromocytoma development in Pten(+/-) mice
ENDOCRINE-RELATED CANCER 23 7-11. .
-
Papathomas TG; Pucci E; Giordano TJ; Lu H; Duregon E; Volante M; Papotti M; Lloyd RV; Tischler AS; van Nederveen FH; Nose V; Erickson L; Mete O; Asa SL; Turchini J; Gill AJ; Matias-Guiu X; Skordilis K; Stephenson TJ; Tissier F; Feelders RA; Smid M; Nigg A; Korpershoek E; van der Spek PJ; Dinjens WN; Stubbs AP; de Krijger RR
An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma
AMERICAN JOURNAL OF SURGICAL PATHOLOGY 40 569-576. .
-
Buj, R; Mallona, I; Diez-Villanueva, A; Barrera, V; Mauricio, D; Puig-Domingo, M; Reverter, JL; Matias-Guiu, X; Azuara, D; Ramirez, JL; Alonso, S; Rosell, R; Capella, G; Perucho, M; Robledo, M; Peinado, MA; Jorda, M
Quantification of Unmethylated Alu (QUAlu): a tool to assess global hypomethylation in routine clinical samples
Oncotarget 7 10536-10546. .
Projectes
- Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
